Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
Objective This study was performed to evaluate the efficacy of daily subcutaneous enoxaparin 20 mg in patients with renal failure. Methods This retrospective cohort study included nonsurgical patients aged ≥18 years with a creatinine clearance rate of <30 mL/minute who were prescribed enoxaparin...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | article |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/10725/11514 https://doi.org/10.1177/0300060518799896 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.sagepub.com/doi/full/10.1177/0300060518799896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|